Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

v3.19.1
Stockholders' Equity
3 Months Ended
Mar. 31, 2019
Equity [Abstract]  
Stockholders' Equity

NOTE 4 - STOCKHOLDERS’ EQUITY

 

Series B Convertible Preferred Stock

 

As of March 31, 2019, there was no share of Series B Convertible Preferred Stock outstanding.

 

Series E Preferred Stock

 

There was no Series E Convertible Preferred Stock outstanding as of March 31, 2019.

 

Common Stock Warrants

 

As of March 31, 2019, the Company had warrants outstanding to purchase 182,191 shares of Common Stock with a weighted average remaining life of 3.1 years and a weighted average exercise price of $25.04. There was no activity of the Company’s warrants during the period ended March 31, 2019.

 

Common Stock Options

 

As of March 31, 2019, the Company had 1,466,520 options outstanding and 784,055 options vested and exercisable to purchase its common stock with a weighted average remaining life of 9.0 years and a weighted average exercise price of $10.37. There was no activity of the Company’s options during the period ended March 31, 2019.